ALFA FinderNSE filing, NSE: RELIGARE. Summary written from the filing by ALFA Finder's alert engine.
Religare Enterprises Ltd: key numbers
- Share price
- ₹233.93
- Market cap
- ₹8,065 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- -238.1×Sector 21.0×
- Promoter holding
- 31.26%+0.70% QoQ
- FII holding
- 9.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Earnings Call Transcript: Key Takeaways
Consolidated H1 loss of ₹145 Cr persists; profit rests on Care Health's Ind AS PBT (₹392 Cr, +42%) while NBFC and broking remain small and in build-out.
Religare Enterprises Investor Presentation: Key Takeaways
Religare H1 FY27 consolidated total income Rs4,717 Cr (+19% YoY); PAT loss Rs145 Cr vs Rs54 Cr profit last year. Care GWP growth drives insurance; Finvest lending restarted 6 Nov 2026.
Religare Enterprises Q2 FY27 Results: Net Loss of ₹97.7 Cr
Religare Enterprises Ltd reported revenue from operations of ₹2,381 Cr (+14.6% YoY) and a net loss of ₹97.7 Cr for Q2 FY27.
- Key figure
- Net loss ₹97.7 Cr
Religare Enterprises Employee Stock Options
Religare Enterprises' NRC granted 25,998 stock options under its ESOP 2019 scheme. Options vest in 5 equal annual tranches at Rs. 230.78 per share exercise price.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Religare Enterprises Board Meeting Date
Religare Enterprises intimated a board meeting on November 12, 2026 to consider unaudited standalone and consolidated results for the quarter ended September 30, 2026. The trading window stays closed until November 14, 2026.
Other other announcement announcements
All →Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr
Capri Global Capital Other Announcement
Capri Global Capital filed its monthly RBI ALM statement (structural liquidity and interest rate sensitivity) for October 2026, unaudited. This is a routine regulatory return with no new financing or corporate event.